exsulin's Phase II study, E-201, is currently enrolling patients. The study is being conducted at two major diabetes center – one in the U.S. and one in Canada. For more details on the clinical trial, go to www.clinicaltrials.gov (Identifier NCT0099540).

Future trials are planned for patients with Type 1 and Type 2 Diabetes.